日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2-Positive Solid Tumors.

针对 Claudin 18.2 阳性实体瘤表达 T 细胞抗原偶联物的 T 细胞的临床前开发

Xu Stacey X, Wang Ling, Ip Philbert, Randhawa Ritu R, Benatar Tania, Prosser Suzanna L, Lal Prabha, Khan Alima Naim, Nitya-Nootan Thanyashanthi, Thakor Gargi, MacGregor Heather, Hayes Danielle L, Vucicevic Andrea, Mathew Princy, Sengupta Sadhak, Helsen Christopher W, Bader Andreas G

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

MRX34(一种脂质体 miR-34a 模拟物)在晚期实体瘤患者中的 1 期研究

Hong, David S; Kang, Yoon-Koo; Borad, Mitesh; Sachdev, Jasgit; Ejadi, Samuel; Lim, Ho Yeong; Brenner, Andrew J; Park, Keunchil; Lee, Jae-Lyun; Kim, Tae-You; Shin, Sangjoon; Becerra, Carlos R; Falchook, Gerald; Stoudemire, Jay; Martin, Desiree; Kelnar, Kevin; Peltier, Heidi; Bonato, Vinicius; Bader, Andreas G; Smith, Susan; Kim, Sinil; O'Neill, Vincent; Beg, Muhammad S

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

MRX34(一种脂质体 miR-34a 模拟物)的 I 期研究,每周两次给药,用于治疗晚期实体瘤患者。

Beg, Muhammad S; Brenner, Andrew J; Sachdev, Jasgit; Borad, Mitesh; Kang, Yoon-Koo; Stoudemire, Jay; Smith, Susan; Bader, Andreas G; Kim, Sinil; Hong, David S

PDL1 Regulation by p53 via miR-34

p53通过miR-34调控PDL1

Cortez, Maria Angelica; Ivan, Cristina; Valdecanas, David; Wang, Xiaohong; Peltier, Heidi J; Ye, Yuping; Araujo, Luiz; Carbone, David P; Shilo, Konstantin; Giri, Dipak K; Kelnar, Kevin; Martin, Desiree; Komaki, Ritsuko; Gomez, Daniel R; Krishnan, Sunil; Calin, George A; Bader, Andreas G; Welsh, James W

Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer

miR-200c的治疗性递送可增强肺癌的放射敏感性

Cortez, Maria Angelica; Valdecanas, David; Zhang, Xiaochun; Zhan, Yanai; Bhardwaj, Vikas; Calin, George A; Komaki, Ritsuko; Giri, Dipak K; Quini, Caio C; Wolfe, Tatiana; Peltier, Heidi J; Bader, Andreas G; Heymach, John V; Meyn, Raymond E; Welsh, James W

Quantification of therapeutic miRNA mimics in whole blood from nonhuman primates

对非人灵长类动物全血中治疗性 miRNA 模拟物进行定量分析

Kelnar, Kevin; Peltier, Heidi J; Leatherbury, Neil; Stoudemire, Jay; Bader, Andreas G

miR-34 - a microRNA replacement therapy is headed to the clinic

miR-34——一种microRNA替代疗法即将进入临床试验阶段

Bader, Andreas G

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

microRNA miR-34a 通过直接抑制 CD44 来抑制前列腺癌干细胞和转移。

Liu, Can; Kelnar, Kevin; Liu, Bigang; Chen, Xin; Calhoun-Davis, Tammy; Li, Hangwen; Patrawala, Lubna; Yan, Hong; Jeter, Collene; Honorio, Sofia; Wiggins, Jason F; Bader, Andreas G; Fagin, Randy; Brown, David; Tang, Dean G

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

利用中性脂质乳剂进行肿瘤抑制性microRNA模拟物的全身递送可抑制小鼠肺部肿瘤。

Trang, Phong; Wiggins, Jason F; Daige, Christopher L; Cho, Chris; Omotola, Michael; Brown, David; Weidhaas, Joanne B; Bader, Andreas G; Slack, Frank J

The promise of microRNA replacement therapy

微RNA替代疗法的前景

Bader, Andreas G; Brown, David; Winkler, Matthew